Societal CDMO Inc
F:RAH
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
N/A
N/A
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one RAH stock under the Base Case scenario is 1.35 EUR. Compared to the current market price of 1.58 EUR, Societal CDMO Inc is Overvalued by 15%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Societal CDMO Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for RAH cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Societal CDMO Inc
Balance Sheet Decomposition
Societal CDMO Inc
Current Assets | 53.5m |
Cash & Short-Term Investments | 8.1m |
Receivables | 29.4m |
Other Current Assets | 16m |
Non-Current Assets | 100m |
PP&E | 54.8m |
Intangibles | 43.3m |
Other Non-Current Assets | 1.9m |
Current Liabilities | 50m |
Accounts Payable | 1.3m |
Accrued Liabilities | 11.4m |
Other Current Liabilities | 37.3m |
Non-Current Liabilities | 44.8m |
Long-Term Debt | 339k |
Other Non-Current Liabilities | 44.5m |
Earnings Waterfall
Societal CDMO Inc
Revenue
|
94.6m
USD
|
Cost of Revenue
|
-76.5m
USD
|
Gross Profit
|
18.1m
USD
|
Operating Expenses
|
-21.7m
USD
|
Operating Income
|
-3.6m
USD
|
Other Expenses
|
-9.7m
USD
|
Net Income
|
-13.3m
USD
|
Free Cash Flow Analysis
Societal CDMO Inc
USD | |
Free Cash Flow | USD |
Societal CDMO reported a revenue jump to $23.6 million for Q3 2023, up from $21.6 million the previous year, citing increased demand for Verapamil products. Despite the rise, a net loss widened to $4.6 million ($0.05 per diluted share) from $3.3 million ($0.06 per diluted share), and adjusted EBITDA fell to $2.8 million from $3.8 million. For the nine months, revenue inched up to $66.9 million from $65.9 million, while net loss also grew to $12.5 million. The company is streamlining operations, expecting to reduce annualized costs by $5.5 million and revising 2023 revenue guidance to $92-$94 million, with adjusted EBITDA projected at $11.5-$13 million.
What is Earnings Call?
RAH Profitability Score
Profitability Due Diligence
Societal CDMO Inc's profitability score is 33/100. The higher the profitability score, the more profitable the company is.
Score
Societal CDMO Inc's profitability score is 33/100. The higher the profitability score, the more profitable the company is.
RAH Solvency Score
Solvency Due Diligence
Societal CDMO Inc's solvency score is 44/100. The higher the solvency score, the more solvent the company is.
Score
Societal CDMO Inc's solvency score is 44/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
RAH Price Targets Summary
Societal CDMO Inc
Dividends
Current shareholder yield for RAH is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Recro Pharma, Inc. is a pharmaceutical company, which engages in the contract development and manufacturing organization (CDMO). The company is headquartered in Exton, Pennsylvania and currently employs 258 full-time employees. The company went IPO on 2014-03-07. Societal CDMO is principally focused on solving various manufacturing problems. The company is a CDMO providing therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging and logistics services to the global pharmaceutical market. In addition to its experience in handling Drug Enforcement Agency (DEA) controlled substances and developing and manufacturing modified-release dosage forms, the Company has the ability to deliver on its clients pharmaceutical development and manufacturing projects. The company conducts its operations in Gainesville, Georgia and San Diego, California.
Contact
IPO
Employees
Officers
The intrinsic value of one RAH stock under the Base Case scenario is 1.35 EUR.
Compared to the current market price of 1.58 EUR, Societal CDMO Inc is Overvalued by 15%.